Aspire Biopharma Stock (NASDAQ:ASBP)

Ownership Financials Chart

Previous Close

$0.35

52W Range

$0.20 - $15.80

50D Avg

$0.42

200D Avg

$1.99

Market Cap

$22.03M

Avg Vol (3M)

$22.41M

Beta

0.67

Div Yield

-

ASBP Company Profile

Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Apr 11, 2022

Website

ASBP Performance

ASBP Financial Summary

	Dec 23	Dec 22
Revenue	-	-
Operating Income	$-358.59K	$-596.49K
Net Income	$-359.07K	$-597.12K
EBITDA	$-358.59K	$-596.49K
Basic EPS	$-0.01	$-0.01
Diluted EPS	$-0.01	$-0.01

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
SNSE	Sensei Biotherapeutics, Inc.
ICU	SeaStar Medical Holding Corporation
NXTC	NextCure, Inc.
LEXX	Lexaria Bioscience Corp.
GOVX	GeoVax Labs, Inc.
THAR	Tharimmune, Inc.
ANL	Adlai Nortye Ltd. American Depositary Shares
CLRB	Cellectar Biosciences, Inc.
FBLG	FibroBiologics, Inc. Common Stock
PALI	Palisade Bio, Inc.